{"schema_version":"alpha-profile-public-v1","slug":"nancy-whiting-pharm-d","canonical_url":"https://registry.alpha.ac/people/nancy-whiting-pharm-d","as_of":"2026-09-21T17:30:14.118178+00:00","published_at":"2026-09-02T02:37:23.292944+00:00","last_reviewed_at":"2026-05-15T22:28:30.45+00:00","identity":{"display_name":"Nancy Whiting, Pharm.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Boundless Bio, Inc.","company_slug":"boundless-bio-inc","exchange":"NASDAQ","ticker":"BOLD","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=nancy-whiting-pharm-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=nancy-whiting-pharm-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["CEO of Recludix Pharma since September 2021 developing treatments for inflammatory disease and cancer. Spent approximately 15 years at Seagen Inc. in various executive roles including EVP of Corporate Strategy and EVP of Late Stage Development, playing central role in development of multiple approved cancer medicines."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Boundless Bio, Inc.","organizationId":"boundless-bio-inc","title":"Director","period":"2023-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Boundless Bio, Inc.","company_slug":"boundless-bio-inc","exchange":"NASDAQ","ticker":"BOLD","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","effective_date":"2025-04-29","last_checked_at":"2026-04-28T23:34:02.069+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Nancy Whiting, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:28:30.630315+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BOLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T22:28:30.533148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Nancy Whiting, Pharm.D. currently serves as Director at Boundless Bio, Inc..","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:28:30.595692+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BOLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T22:28:30.533148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Nominating/Governance"],"claim_text":"Nancy Whiting, Pharm.D. serves on Nominating/Governance.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:28:30.61315+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BOLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T22:28:30.533148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Recludix Pharma","claim_text":"Nancy Whiting, Pharm.D. is linked to Recludix Pharma as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:28:30.730655+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BOLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T22:28:30.533148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer","claim_text":"Nancy Whiting, Pharm.D. is also listed as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:28:30.714413+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BOLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T22:28:30.533148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Nancy Whiting, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:28:30.663121+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BOLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T22:28:30.533148+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Nancy Whiting, Pharm.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T22:28:30.647233+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BOLD DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-15T22:28:30.533148+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:nancy-whiting-pharm-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2023-01-01 · current","organization":"Boundless Bio, Inc.","organization_id":"boundless-bio-inc"},"claim_text":"Director at Boundless Bio, Inc. (2023-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/nancy-whiting-pharm-d#profile","url":"https://registry.alpha.ac/people/nancy-whiting-pharm-d","dateModified":"2026-05-15T22:28:30.45+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/nancy-whiting-pharm-d#person","name":"Nancy Whiting, Pharm.D.","url":"https://registry.alpha.ac/people/nancy-whiting-pharm-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Boundless Bio, Inc.","tickerSymbol":"NASDAQ: BOLD"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","memberOf":{"@type":"Organization","name":"Boundless Bio, Inc.","url":"https://registry.alpha.ac/companies/boundless-bio-inc","tickerSymbol":"NASDAQ: BOLD"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1782303/000095017025060073/bold-20250429.htm","name":"BOLD DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/nancy-whiting-pharm-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-15T22:28:30.45+00:00","observed_at":"2026-09-21T17:30:14.118178+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"nancy-whiting-pharm-d","canonical_url":"https://registry.alpha.ac/people/nancy-whiting-pharm-d"},"publication":{"published_at":"2026-09-02T02:37:23.292944+00:00","last_reviewed_at":"2026-05-15T22:28:30.45+00:00","as_of":"2026-09-21T17:30:14.118178+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/nancy-whiting-pharm-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/nancy-whiting-pharm-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/nancy-whiting-pharm-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}